USP revised about thirty Ophthalmic Ointment Monographs
Recommendation

5/6 May 2026
Challenges and Solutions for Packaging / Devices & Single Use Systems
On July 29, 2016, the United States Pharmacopeia (USP) posted a new Revision Bulletin regarding approximately thirty Ophthalmic Ointment Monographs.The revised monographs became official on August 1, 2016.
The USP Chemical Medicines Expert Committees 1 to 6 have revised the monographs following the revision of general chapter <771> which became official on May 1, 2016 (USP 39).
The purpose of the revision is to replace the requirement to comply with the entire content of the USP general chapter Ophthalmic Products—Quality Tests <771> (whose former title was Ophthalmic Ointments) with a requirement to comply only with the subsection for Particulate and Foreign Matter in Ophthalmic Products—Quality Tests <771>, and with the section for Container Content for those monographs where the requirement for Minimum Fill was deleted.
The Revision Bulletins for the respective monographs supersede the currently official version of these monographs. The Revision Bulletin will be incorporated in the First Supplement to USP 40–NF 35.
For more information please visit the USP Revision Bulletins website.
Related GMP News
23.04.2026Revised Chapter 2.8.25 HPTLC of Herbal Products” Published in Ph. Eur. 13.1
22.04.2026USP plans new General Chapter on Supercritical Fluid Chromatography (SFC)
08.04.2026FDA Warning Letter: Batch Release Without Appropriate Laboratory Evidence
01.04.2026FDA Warning Letter - From Garbage Bags with Analytical Records to Pre-signed and Backdated Data
31.03.2026Questions and Answers on System Suitability Tests (SST) - Part 3
31.03.2026Statistical Process Control (SPC) - Survey Result Report now Available


